Healthcare systems worldwide are facing unprecedented pressure, from the rise in chronic diseases and aging populations to fragmented healthcare and over-stretched resources. The result? Delayed, ...
Thanks to new regulatory frameworks like the Food and Drug Administration’s Breakthrough Therapy designation, drugs are coming to market faster than ever. A 2024 analysis of drugs included in this ...
The FDA now accepts RWE for device submissions without needing identifiable patient data, facilitating the use of large, de-identified databases. This change addresses previous limitations that ...
Mayo Clinic clinicians are starting to explore how they might use healthcare-specific large language models – accessed through a generative artificial intelligence chat application – to enhance ...
A day in the life of a DBA (database administrator) can be quite hectic. The DBA is required to maintain production and test environments while at the same time keeping an eye on active application ...
Protocol amendment for ENSEMBLE study: A multicenter, randomized, phase III trial to test the superiority of consolidation irinotecan, capecitabine and oxaliplatin vs capecitabine and oxaliplatin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results